2025 International Congress Archives

A 37 years-old man with Epilepsy and Progressive Autoimmune Ataxia

J. Balderas Juárez, A. Zepeda Rodríguez, R. Padilla García (Mexico City, Mexico)
A 6-Year Longitudinal Analysis from the Parkinson’s Progression Markers Initiative on Non-Motor Symptom Severity and Progression in GBA1-associated vs. sporadic Parkinson’s Disease

M. Fonseca, D. Ramos, V. Di Foggia, R. Costa, J. Holenz, D. Simon, T. Marker Initiative (Coronado, Portugal)
A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

ME. Mellaci (SÃO PAULO, Brazil)
A Case for Novel Phenotypes Associated with Digenic CHMP2B-LRRK2 Mutations

D. Vijaywargiya, T. Chabrashvili (Liverpool, USA)
A Case of “Rabbit” Syndrome with Concomitant Tongue Tremor

J. Martin, A. Juell, J. Jacobson (San Antonio, USA)
A case of ataxia and muscle stiffness in EEF2 gene mutation with associated anti-GAD antibodies

H. Arrowood, J. Tamai (Poughkeepsie, USA)
A Case of Autosomal Dominant Hypocalcemia Presenting with Parkinsonism and Widespread Brain Calcifications

J. Barnes, M. Boca (Bristol, United Kingdom)
A case of bilateral asterixis following hemichorea-hemiballism due to bilateral internal carotid artery stenosis

S. Mamada, R. Yokoyama, K. Seo, H. Kawasaki, Y. Ito, G. Oyama, T. Yamamoto (Saitama, Japan)
A Case of CANVAS Misdiagnosed as Subacute Labyrinthitis and Meniere’s Disease

Y. Nishonova, B. Mukhammedaminov, N. Aripova, L. Kenjaeva (Tashkent, Uzbekistan)
A Case of Decreased Disability After Stroke: Lesional Modulation of Essential Tremor

A. Welleford, T. Yamasaki, D. Ionel (Lexington, USA)
A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male

B. Akkineni, L. Teshome, E. Krause (Austin, USA)
A Case of Mixed Presentation of 4R Tauopathies

S. Ghourchian, A. Kay (Brooklyn, USA)
A case of Parkinson’s Disease whose Daily Levodopa/Carbidopa Intestinal Gel dose has been determined by her spouse and prevented Long-term Fluctuations

Y. Okuma (Izunokuni, Japan)
A Case of SGCE Myoclonus-Dystonia diagnosed in a 70-Year-Old Male

V. Mazo, P. Atit, N. Shneyder, N. Rincon-Flores (Tampa, USA)
A Case of Tardive Dystonia Treated with Bilateral Radiofrequency Ablation and Deep Brain Stimulation

K. Kim, S. Horisawa, T. Taira (Tokyo, Japan)
A Case Report of Two Affected Siblings with Spinocerebellar Ataxia Type 1

S. Fu, U. Agarwal, I. Goldszer (Detroit, USA)
A Clinical Overlap Presentation of Episodic Ataxia Type 2 and Periodic Paralysis with a Novel Mutation in CACNA1A

C. Vila, K. Minks, P. Morrison (Rochester, USA)
A Comparative Analysis of Water-Based versus Land-Based Exercise Interventions for Improving Quality of Life in Parkinson’s Disease: A Systematic Review

S. A. Hassan, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. M. Elsayed (Giza, Egypt)
A Comparison of Coordinated Reset and Low-Frequency Vibrotactile Stimulation for the Treatment of Parkinson’s Symptoms

E. Kabasenche, M. Gutierrez, M. Fisher, C. Hauptmann, P. Luu, D. Tucker (Eugene, USA)
A Comparison of the Efficacy and Safety of Magnetic Resonance-Guided Focused Ultrasound Ablation (MRgFUS) and Deep Brain Stimulation (DBS) in the Treatment of Tremor in Parkinson’s Disease

I. Fink, L. Motta, G. Sorato, M. Rosa, D. Gonçalves, V. Serafim, L. Lima, R. Juvêncio, J. Lopes, L. Koehler, C. Rieder (Porto Alegre, Brazil)
A Comprehensive Exploration of the Quality of Life and Caregiver Burden in Multiple System Atrophy

I. Karagoz, H. Morris, H. Houlden, V. Chelban (London, United Kingdom)
A Cross-sectional Gender Gap Meta-analysis in Movement Disorders Publishing Field

D. Garg, Z. Aldaajani, M. Auffret, T. Capato, M. Picillo, C. Trenkwalder, L. Ali, M. Armstrong, M. Bruno, V. Bruno, E. Minakawa, W. Kamel, S. Fox, D. Olszewska (New Delhi, India)
A Dance with Sydenham, it’s Never Too Late to Tango

M. Gomez Rodriguez, B. Cheon, S. Kenniff (Pembroke Pines, USA)
A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS

C. van Horne, G. Quintero, J. Hixson (Lexington, USA)
A Double-Blind, Cross-Over Pilot Study Comparing Adaptive Deep Brain Stimulation (aDBS) to Conventional DBS in Parkinson’s Disease

T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)
A Four-Arm Randomized Controlled Trial on the Effects of Multi-Dimensional Cognitive Intervention in Parkinson’s Disease with Mild and Subjective Cognitive Decline (REMIND)

P. Huang, C. Gao, YY. Tan, SD. Chen (Shanghai, China)
A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease

D. Chouhan, A. Bello, K. Cullen, J. Duda (Philadelphia, USA)
A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies

C. Gibbons, T. Levine, B. Bellaire, R. Freeman (boston, USA)
A mindfulness-based intervention course in pre-manifest Huntington’s disease: analysis of pilot data

S. Berman, R. Devenyi, V. Vaughn, G. Toti, A. Lasker (Camden, USA)
A Mixed Reality Multimodal System for Objective Assessment of Motor and Cognitive Functions in Neurodegenerative Diseases

D. Hemmerling, J. Stepien, W. Szecowka, A. Channarayapatna Srinivasa, M. Rudzińska-Bar, M. Wojcik-Pedziwiatr, . (Krakow, Poland)
A multi-center, randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson’s disease (DATSZ-PD study)

M. Takahashi, J. Koh, T. Shimokawa, Y. Kajimoto, T. Takeshima, H. Ito (Hirakata, Osaka, Japan)
A Multi-Transcriptional Risk Score Approach to Parkinson’s Disease Prediction

L. Gilchrist, O. Pain, A. Noyce, K. Brolin, M. Periñán, P. Proitsi (London, United Kingdom)
A Multidimensional Biomarker Panel for The Early Detection of Parkinson’s Disease

N. Shebl, S. Mowafi, A. Arafa, M. Wahid, M. Salama (Mansoura, Egypt)
A Multidomain Fall Prevention Program: Perspectives of People with Parkinson’s Disease and their Care Partners

L. Goh, A. Darmali, C. Koch, S. Tran, S. Paul, C. Canning, S. Edwards, S. Harkness, R. Savage, L. Webster, G. Zelma, N. Allen (Camperdown, Australia)
A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease

F. Al-Zaidi (Almaty, Kazakhstan)
A novel homozygous mutation in PANK2 gene mutation in a South- Asian male with typical PKAN

H. Chovatiya (Surat, India)
A novel potential imaging biomarker for Parkinson’s disease: Optical Coherence Tomography.

G. Napoli, R. Santangelo, G. Rugarli, R. Balestrino, E. Sarasso, L. Ferini-Strambi, M. Filippi, F. Agosta (Milan, Italy)
A Novel Quantitative Assessment to Evaluate Functional Impairment in Parkinson’s Disease

V. Vanchinathan, M. Farah, A. Singh, C. Zhang, N. Osei-Owusu, R. Desai, R. Palani, J. Hamkins, M. Zwernemann, S. Grill, A. Pantelyat, J. Brašić (Baltimore, USA)
A Novel Therapeutic Targeting the tPA-NMDAr Interaction for Parkinson’s Disease

M. Blanc, E. Su, D. Torrente, B. Zhang, D. Vivien, F. Lesept, N. Deletage (Lyon & Caen, France)
A novel virtual home-safety fall prevention program for Parkinson’s Disease

M. Afshari, V. Palakuzhy, G. Jones, A. Hernandez, B. Ouyang, C. Goetz (Chicago, USA)
A Pan-Indian Genome-Wide Association Study of Parkinson’s Disease

A. Kishore, A. Sreelatha, A. Tenghe, R. Borgohain, D. Puthenveedu, R. Rajan, L. Ricardo, P. Pal, R. Mridula, M. Urulangod, R. Yadav, S. Mehta, H. Kumar, P. Agarwal, N. Kumar, P. Kukkle, S. Desai, M. Sharma (Tubingen, Germany)
A personalized gait signature assay in Parkinson’s disease

H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)
A Phase 1b Study to Investigate Safety and Tolerability of Repeated Subcutaneous Doses of HER-096 in Subjects with Parkinson’s Disease

K. Holmström, K. Jääskeläinen, N. Kulesskaya, J. Koskinen, R. Holmnäs, A. Vuolanto, A. Domanska, M. Engström, P. Vainio, M. Scheinin, C. Videbaek, A. Tornio, Z. Lovro, F. Scheperjans, J. Rinne, H. Huttunen (Espoo, Finland)
A Phase 2 Study of Risvodetinib in Untreated Parkinson’s Disease

M. Werner, C. Meyer, E. Mancino, C. Klint, J. Pellecchia, A. Mcgarry, K. Kieburtz, C. Olanow (Atlanta, USA)
A Phase I Study of TR-012001, a Nasal Levodopa, in Healthy Adult Japanese Male Subjects

R. Ise, M. Kaneko, S. Haruta, Y. Sonoda, Y. Akiyoshi, C. Date, S. Nakano, T. Akagi, Y. Sumiyoshi, S. Kanazashi, I. Nagata, H. Fukase (Tokyo, Japan)
A Phase II Randomized, Parallel, Double-blind, Placebo-controlled Study of the Efficacy and Safety of WD-1603 in Subjects with Parkinson’s Disease

X. Wei, L. Chen, X. Hu, J. Guo, C. Liu, J. Wang (Shanghai, China)
A Proof-of-Concept Study of TR-012001, a Nasal Levodopa, in Patients With Parkinson’s Disease With OFF Episodes, Without Dopa Decarboxylase Inhibitor

M. Nomoto, H. Yabe, R. Ando, Y. Sumiyoshi, T. Akagi, R. Ise, Y. Akiyoshi, C. Date, S. Nakano, R. Suzuki, Y. Sonoda, S. Haruta, S. Kanazashi, A. Mori, I. Nagata (Tokyo, Japan)
A Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes (proATYP).

M. Makrygianni, D. Potamianou, T. Pipikos, M. Xilouri, C. Mourmouris, A. Sarafi, L. Florentin, M. Stamelou (Athens, Greece)
A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

A. Eubank, A. Thatikala, M. Garza, H. Khan, T. Virmani, R. Dhall, J. Talburt, L. Larson-Prior, F. Prior (Little Rock, USA)
A Quantitative Analysis of the Link between Weight Gain and Charge Efficiency in DBS

C. O'Keeffe, F. Ruggieri, E. Donlon, A. Mathew, C. Moran, R. Walsh (Dublin, Ireland)
A Quantitative Systems Disease Model for Progressive Supranuclear Palsy.

H. Geerts, S. Short (Radnor, USA)
A randomised controlled feasibility study of a technology-assisted home-based aerobic exercise program for individuals with Parkinson’s disease

S. Neo, Z. Yee, W. Li, HL. Ng, R. Hoe, C. Chung (Singapore, Singapore)
A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease

A. Puig-Davi, A. Moreu-Valls, S. Martinez-Horta, G. Kulisevsky, J. Rodriguez-Antiguedad, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
A Randomized, Double-blind Phase 3 Trial of Amlenetug Versus Placebo in Patients with MSA: The MASCOT Trial

L. Kjærsgaard, M. Nørbæk Jørgensen, S. Zanigni, J. Wiedemann, J. Luthman (Valby, Denmark)
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the NLRP3 Inhibitor Vent-02 in Patients with Mild to Moderate Parkinson’s Disease

A. Matta, X. Valencia, K. Pike, L. Warner, O. Spiegelstein, M. Bigal (Waltham, USA)
A rapidly progressive multiple system atrophy-cerebellar variant model presentingα-synuclein oligomer spreading and phosphorylated α-synuclein aggregate formation accompanied with glial inflammation

D. Matsuse, H. Yamaguchi, Y. Nishimura, H. Sekiya, K. Masaki, T. Tanaka, T. Saiga, M. Harada, K. Kira, D. Dickson, K. Fujishima, E. Matsuo, K. Tanaka, R. Yamasaki, N. Isobe, J. Kira (Fukuoka, Japan)
A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission

L. Hong, P. Atit, R. Patil, E. Sandberg, A. Makarova (Tampa, USA)
A Rare Case of Dipeptidyl-peptidase-like protein 6 (DPPX) Antibody-Associated Encephalitis

A. Bata, J. Frey (Morgantown, USA)
A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)

J. Cohen (Jacksonville, USA)
A Resting-State fMRI Study of Regional Homogeneity about Pain in Parkinson’s Disease

CJ. Mao, JY. Wu, J. Cheng, YJ. Luo, QM. Jiang (Suzhou, China)
A retrospective analysis of an FMD IDC: considerations that impact outcomes.

D. Del Papa, T. Najafi, J. Harris, T. Peabody, Y. Villalobos, K. Mcinerney, J. Wohn, M. Feldman, J. Margolesky (Miami, USA)
A retrospective study on thyroid dysfunction mimicking Parkinsonian symptoms

D. Mukhammedaminova, L. Kenjaeva (Tashkent, Uzbekistan)
A Retrospective, Multicenter, Harmonized Data Collection for Uncovering DBS Long-Term Axial Response

M. Guidetti, S. Marceglia, P. Andrade, S. Babakry, MT. Barbe, T. Bocci, F. Bodlee, S. Bonvegna, H. Bronte-Stewart, S. Cascino, CE. Casselton, A. Fasano, M. Fumagalli, S. Giannoni-Luza, IU. Isaias, H. Jergas, MLF. Janssen, AM. Lozano, NV. Maiorana, N. Modugno, S. Oliveri, D. Pedrosa, M. Santilli, Y. Temel, L. Timmermann, D. Urso, V. Visser-Vandewalle, A. Priori (Milan, Italy)
A RNF213 truncating variant causes an autosomal dominant disorder with brainstem and basal ganglia lesions and a Huntington-like phenotype

R. Bovenzi, F. Shen, IJ. Keller Sarmiento, BI. Bustos, L. Kinsley, J. Nichols, D. Krainc, NE. Mencacci (Chicago, USA)
A Scoping Review of Psychological Interventions across domains to improve Quality of Life in Persons with Parkinson’s Disease

S. Desai, D. Desai (Anand, India)
A scoping review of safer mobility behaviour for falls prevention: Implications for people with Parkinson’s disease.

D. Cheung, J. Wesson, S. Paul, L. Mackenzie, L. Goh, C. Canning, L. Almeida, M. Enright, N. Allen (Camperdown, Australia)
A shortened MDS-UPDRS Patient-based item bank increases sensitivity for predicting dopaminergic therapy initiation: A Longitudinal IRT Analysis in early PD

S. Luo, L. Yu, G. Stebbins, T. Mestre, C. Goetz (Durham, USA)
A Snapshot on Advanced Therapies in Essential Tremor: Insights from a Neurology Survey

A. Sanchez Fraga, L. Knight, R. Martuscello, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Munich, Germany)
A Standardised, Semi-automated Computational Approach to the Analysis of Electrophysiology in Orthostatic Myoclonus

N. Jeyakumar, S. Nagaratnam, G. Jeyakumar, P. Becker, F. Chang, V. Fung (Westmead, Australia)
A Study Of Axial Postural Abnormality In Parkinson`s

V. Rama Raju (Hyderabad, India)
A Study of Delayed Specialist Consultation in Parkinson’s Disease Patients in Uzbekistan

L. Kenjaeva, B. Mukhammedaminov, N. Aripova, Y. Nishonova, G. Kendjaeva (Tashkent, Uzbekistan)
A Survey On The Changes Of Non-Motor Symptoms And Quality Of Life In Patients With Parkinson’s Disease After Bilateral Subthalamic Nucleus Deep Brain Stimulation

J. Wang, D. Zhu, Y. Gao, L. Wang, D. Li, B. Sun, Y. Wu, X. Qiu (Shanghai, China)
A Systematic Review of Motor Improvement Caused by Deep Brain Stimulation in Post-Stroke Movement Disorder Patients

AJ. Ribeiro, L. Koehler, MF. Felippe, J. Lopes, G. Sorato, G. Maia, V. Xavier, AC. Petry, M. da Rosa, M. Neto, CR. Rieder (Porto Alegre, Brazil)
A Systematic Review on the Reliability of Data-Driven Parkinson’s Disease Subtypes

D. Teixeira-Dos-Santos, R. Ravazio, C. Mattjie, A. De-Oliveira-Franco, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, MA. de Bastiani, MA. Machado Schlindwein, L. Angi Souza, T. Hugentobler Schlickmann, S. Duarte Pinto, A. Bieger, R. C. Barros, E. R. Zimmer, AF. Schumacher Schuh (Porto Alegre, Brazil)
A Systematic Site Selection Approach to Ensure Efficient and Diverse Participant Recruitment to a Large-Scale Multi-Arm, Multi-Stage Platform Trial for Parkinson’s

G. Mills, M-L. Zeissler, O. Bandmann, R. Barker, J. Carpenter, S. Collins, J. Duffen, S. Gandhi, L. Houlden, C. Gonzalez-Robles, C. Mcalpine, K. Mcfarthing, C. Pugh, A. Schapira, A. Schrag, C. Shakeshaft, T. Foltynie, C. Carroll (London, United Kingdom)
A Tailored Approach to Parkinson’s Disease: The Influence of Hormonal Status in Women

B. Perraud, I. Beaulieu-Boire (Sherbrooke, Canada)
A Unique Case of Reverse Hemifacial Spasm Reproducible Upon Neck Extension

S. Lee, A. Ohno, K. Frei (Loma Linda, USA)
A unique genetic duality: GAK and SCN4A Mutations in Myasthenic Syndrome and Early-Onset Parkinsonism in a Peruvian woman: A Case Report

W. Trillo Alvarez, A. Carpio Peña, L. Delgado Villanueva, A. Gomez Azcue, H. Paz-Soldan Candia, M. Nieto Rosas, D. Flores Barragan, F. Arismendi Gomez (AREQUIPA, Peru)
A VUS and the Value of a Biomarker in Ataxia with Oculomotor Apraxia Type 2

F. Brito, A. Guerra, R. Kauark, G. Nunes, M. Vassoler, F. Nascimento, C. Nascimento, G. Piñeiro, . (Salvador, Brazil)
A young Peruvian woman with a stairs conundrum: Scapuloperoneal spinal muscular atrophy (SPSMA) due to a TRPV4 mutation case report

W. Trillo Alvarez, J. Escalante Ortiz, L. Delgado Villanueva, R. Huanca Machon, K. Choque Pereyra, C. Pinto Torres, A. Carpio Peña, D. Cahuana Ibarra, S. Meza Caceres, C. Carlosviza Diaz (AREQUIPA, Peru)
Aberrations in Voluntary Thought Initiation: Parallels to Motor Freezing in Basal Ganglia Dysfunction

S. Shugar, N. Choudhury, D. Nolasco, B. Carr (Gainesvile, USA)
Absence of identifiable neuropathological correlates of cognitive impairment in multiple system atrophy

S. Radmard, T. Ma, J. Agin-Liebes (Atlanta, USA)
Acceptability, Feasibility, and Appropriateness of wearable technology in Lewy body dementia

B. Patel, S. Staras, T. Manini, M. Armstrong (Gainesville, USA)
Access to Allied Health Services by People Living with Parkinson’s Disease: A Qualitative Study

C. Wong, S. Dennis, N. Allen, S. Paul (Camperdown, Australia)
Accuracy of diagnostic tests in determining clinical improvement following shunt in normal pressure hydrocephalus (NPH) – a systematic review and meta-analysis

A. Elavarasi, A. Aliyar, S. Desai, D. Dash (New Delhi, India)
Accuracy of the Tanner’s Questionnaire and the REM Sleep Behavior Disorder Single-Question Screen as Screening Tools for Parkinson’s Disease in a Brazilian Cohort

G. Bolner, G. Magalhães Pereira, N. Medeiros Soares, C. Cenci Sangali, D. Dos Santos, T. de Carvalho, C. Mello Rieder, A. Schumacher Schuh (Porto Alegre, Brazil)
Action-Induced Dystonic Opisthotonus as an Atypical Presentation in Ataxia Telangiectasia

TL. Lee (Tainan, Taiwan)
Active-Learning Methodologies in the Teaching of Movement Disorders in Neurology Residency

F. Rolim, A. Lima Verde, P. Matos, A. Gomes, V. Aragão, A. Marinho, F. Carvalho (Fortaleza, Brazil)
Activity and Position-Dependent Hemifacial Spasm Caused by Neurovascular Compression: A Case Report

C. Adams, T. Peckham, A. Samii (Memphis, USA)
Acute Chorea in the Emergency Department: A Prospective Cohort Study

AS. Lima Verde, F. Rolim, A. Catunda, AR. Marinho, F. Carvalho (Fortaleza, Brazil)
Acute onset of left laterocollis with jerky dystonic tremor as a presentation of uncontrolled hyperglycemia

H. Chovatiya (Surat, India)
Adaptive Deep Brain Stimulation Algorithmic Performance Evaluation Through Symptom Driven Metrics

K. Balagula, J. Yao, M. Shcherbakova, A. Hahn, P. Starr, S. Little (San Francisco, USA)
Adaptive Deep Brain Stimulation for Parkinson’s Disease in Routine Clinical Care: First Experiences

B. Keulen, M. de Neeling, M. Stam, D. Hubers, L. Boon, R. de Bie, B. van Wijk, P. Schuurman, M. Bot, M. Beudel (Amsterdam, Netherlands)
Adaptive deep brain stimulation for tremor control in Parkinson’s disease

A. Ramirez-Zamora, T. Herrington, M. Beudel, J. Ostrem, S. Little, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, N. Morelli, H. Bronte-Stewart (Gainesville, USA)
Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach

L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret (London, United Kingdom)
Adherence with Digital Outcome Measures in Focal Dystonias

A. Tingin, P. Reyes, F. Qeadan, L. Wright, G. Kilic-Berkmen, S. Bellows, S. Fox, D. Martino, J. Feuerstein, A. Wagle Shukla, A. Deik, R. Barbano, B. Berman, J. Perlmutter, H. Jinnah, S. Pirio Richardson (Albuquerque, USA)
Adult-onset ataxia with oculomotor apraxia type 4 with severe hypoalbuminemia, generalized edema and obesity

M. Paucar (Stockholm, Sweden)
Adult-Onset Chorea and Psychosis in a 59-Year-Old Man with Elevated Anti-Streptolysin O (aso) Titer

A. Soriano Ballivian, R. Singh, R. Reshi, U. Verma, Z. Khan, O. Los (Oklahoma City, USA)
Adult-Onset Post-Pump Chorea: A Rare Manifestation Post-Cardiac Surgery in a Puerto Rican Patient

E. Pérez-Luciano, C. Morfi-Pagán, D. Lozada-Figueroa, L. Surillo-Dahdah (Ponce, Puerto Rico)
Advancements in Microbiome Research: Total Microbial Load, Differential Absolute Abundance, and Correlations with Immune Transcriptomics

B. Palushaj, M. Chakraborty, I. Porter, G. Reynolds, E. Brooks, Z. He, A. Bhatt, K. Poston (Palo Alto, USA)
Advancing Global Training and Capacity Building in Parkinson’s Genetics through GP2

MT. Periñan, S. Dey, S. Finch, H. Leonard, M. Makarious, K. Atterling Brolin, A. Zirra, K. Step, V. van Midden, YW. Tay, Y. Mecheri, L. Faria-Costa, E. Fernandez-Toledo, V. Flores-Ocampo, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Sevilla, Spain)
Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

A. Wiederhold, C. Gundler (Hamburg, Germany)
Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations

H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett (Richmond, USA)
Advancing MDS Guidelines for Electronic Clinical Outcome Assessments: Best Practices for Validation and Implementation

R. Fuller, M. Skorvanek, M. Monje, M. Tosin, S. Ali, A. Lofald, A. Sanchez Ferro, T. Mestre (Princeton, USA)
Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings

T. Yinesu, Z. Bayu (Addis Ababa, Ethiopia)
Advancing the regulatory maturity of digital health technologies with focus on early intervention, Critical Path for Parkinson’s 3DT initiative

D. Stephenson, C. Coon, J. Cosman, M. Dockendorf, S. Dolan, J. Edgerton, L. Gaetano, E. Goikoetxea, D. Hill, G. Jones, S. Jorgensen, T. Kangarloo, C. Kopil, G. Lee, J. Mammen, A. Mirelman, C. Ollivier, K. Romero, S. Sardar, Y. Xiao, M. Müller, J. Adams (Tucson, USA)
Affordable Aspect of Artificial Intelligence Applied to Tremor’s Analysis Features Extraction Approach based on Archimede’s Spiral Processing

M. Abid, A. Rekik, R. Guizani, S. Laatoui, I. Rekik, S. Ben Amor (Sousse, Tunisia)
Age-related Trends in Amyloid Positivity in Parkinson’s Disease without Dementia

K. Hatano, M. Kameyama, M. Kurihara, K. Ohse, R. Goto, R. Ihara, M. Higashihara, R. Sengoku, Y. Nishina, K. Kanemaru, Y. Saito, S. Murayama, A. Iwata (Tokyo, Japan)
AI-Based Detection of Tremor and Dystonia Using Deep Learning Models: A Novel Approach

A. Mansour, Y. Hassan, H. Afify, A. Naguib (Cairo, Egypt)
AI-Driven Prediction Models for Advanced Parkinson’s Disease: A Data-Driven Approach Using PPMI and CDEPA Criteria

I. Gabilondo, A. Saenz, S. Seijo, A. Ochoa, U. Zalabarria, I. Cuenca, B. Tijero, T. Fernandez, M. Ruiz, M. Acera, J. Gomez, R. Del Pino (Barakaldo, Spain)
AI-Driven Wearable Sensor Monitoring for Improved Assessment of Advanced Treatment Readiness in Parkinson’s Disease – A pilot study

N. Karottki, M. Sander, T. Hørmann Thomsen, B. Biering-Sørensen (Glostrup, Denmark)
AI-Powered Seamless Webcam Assessment for Parkinson’s Disease

J. Lapeña-Motilva, K. Coutinho-García, E. Rangel, JC. Martínez-ávila, D. Pérez-Martinez, M. Hernández Gonzalez-Monje, N. Malpica-González, A. Sánchez-Ferro (Madrid, Spain)
Alpha Synuclein Seeding Activity Drives Disease Heterogeneity in an Animal Model of Multiple System Atrophy

A. Shafique, N. Silver, A. Mao, R. Ferry, I. Martinez-Valbuena, J. Watts, G. Kovacs, N. Visanji (Toronto, Canada)
Alpha-Synuclein Accumulation-Attenuating Effect of Brain-Derived Neurotrophic Factor in Primary Cell Culture Model of Parkinson’s Disease

I. Hlushchuk, MT. Airavaara (Helsinki, Finland)
Alpha-Synuclein Aggregates in the Olfactory Epithelium of Subjects with Parkinson Disease, Dementia, COVID-19, and in Aged Controls

J. Tomlinson, N. Lengacher, A-K. Jochum, J. Franz, L. Flatz, B. Mollenhauer, C. Stadelmann, J. Woulfe, M. Schlossmacher (Ottawa, Canada)
Alpha-Synuclein Amplification Assays Utilizing Real-Time Quaking-Induced Conversion (RT-QuIC) from Non-Invasive Saliva as a Novel Diagnostic Tool for Patients with Parkinson’s Disease

PRA. Sharma, RK. Dhamija (Delhi, India)
Alpha-Synuclein Preformed Fibrils Increase the Frequency of CXCR3+ B-cells in Early-stage Parkinson’s Disease Patients

H. Hong, M. Dean, D. Standaert, H. Qin, E. Benveniste (Birmingham, USA)
Alpha-Synuclein Promotes the Expression and Release of Neurofilament Light Chain from Oligodendrocytes in Multiple System Atrophy

YC. Zheng, WY. Kou, GX. Yang, HH. Cai, C. Yang, SM. Li, BX. Zhu, JY. Wu, Y. Huang, ZW. Yu, T. Feng (Beijing, China)
Alterations in Basal Ganglia Synaptic Density and Thalamic Gray Matter Volume are associated with Motor Signs in Late Life Depression: an 11C-UCB-J PET/MR study.

M. van Cauwenberge, T. Vande Casteele, M. Laroy, K. Vansteelandt, K. van Laere, J. Vanden Stock, F. Bouckaert, L. Emsell, M. Vandenbulcke (Leuven, Belgium)
Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls

D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli (Storrs, USA)
Alterations in gut microbiota composition in VPS35 associated PARK17 mouse model

TH. Yeh, SP. Tsao, HY. Huang, CC. Chiu (Taipei, Taiwan)
Alterations of Plasma Membrane in Parkinson’s disease LRRK2 I1371V iPSC derived Astrocytes contribute to the vulnerability of the niche cells to Extracellular α-Synuclein

I. Datta, R. Banerjee, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Altered Tryptophan Metabolism and the Role of the Kynurenine Pathway in Multiple System Atrophy

R. Nagao, K. Kawabata, Y. Mizutani, H. Watanabe (Toyoake, Japan)
Ameliorating effect of linalool on anxiety disorders in Parkinson’s mice and related mechanisms

F. Lou, M. Li (Shenyang, China)
Amitriptyline-Induced Rabbit Syndrome: A Case of Refractory Oral Vertical Dyskinesia

A. Medhus, E. Krause (Austin, USA)
Amplification Parameters of the Alpha-Synuclein Seed Amplification Assay on CSF Predict the Clinical Subtype of Parkinson’s Disease at 10-Year Follow-Up

P. Grillo, GM. Riboldi, A. Pisani, UJ. Kang, SM. Fereshtehnejad (Pavia, Italy)
Amygdala-predominant Lewy Body Disease is a Lens for Understanding Pathogenesis and the Alpha-synuclein Seeding Assay in Human Postmortem Brain

D. Fischer, L. Vandevrede, W. Seeley, S. Spina, S. Li, W. Lee, T. Lamore, F. Wekselman, A. Lario Lago, L. Grinberg (San Francisco, USA)
An Atypical Case of Ataxia and Hyperkinetic Movements

S. Gunawardena, U. Shuaib (Cleveland, USA)
An Exercise Prescription to Slow the Progression of Parkinson’s Disease

J. Alberts, A. Rosenfeldt, C. Lopez-Lennon, E. Jansen, C. Felix, E. Zimmerman, P. Imrey, H. Fernandez, K. Mckee, L. Dibble (Cleveland, USA)
An Interesting Case of Oculo-Palatal-Pharyngeal Tremor

R. Robinson, A. Oswal, MT. Hu (Oxford, United Kingdom)
Anal Sphincter EMG changes can Progress over Time and can be considered as a Prognostic Marker in MSA

L. Lei, J. Bermejillo, P. Malladi, J. Panicker, A. Batla (London, United Kingdom)
Analgesic Effect of Cannabidiol and Tetrahydrocannabinol(THC) on Pain Sensitivity in Reserpine Model of Parkinson’s Disease

T. Muhammad, A. Isa, H. Tanko (Kaduna, Nigeria)
Analysis of Diagnostic Outcomes and Imaging Features in Patients with Ventriculomegaly and Gait Impairment

C. Espinoza-Vinces, I. Avilés-Olmos, J. Núñez Córdoba, M. Jiménez Vázquez, M. Calvo Imirizaldu, G. Martí-Andrés, M. Luquin (Pamplona, Spain)
Analysis of Emergency Department Encounters and Hospital Admissions of People with Huntington’s Disease

T. Orem, E. Forbes, S. Sillau (Aurora, USA)
Analysis of LRRK2 Exonic Variants in Parkinson’s Disease in Chinese Population

ZY. Qi, YM. Sun, J. Wang (Shanghai, China)
Analysis of OptoGait walking data using machine learning models – Using classification algorithms to assess the risk of falling in Parkinson’s patients

T. Böök, R. Ortiz, J. Honkaniemi (Tampere, Finland)
Analysis of statistical data on patients with Parkinson’s disease.

R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)
Analysis of the Association between SNCA Polymorphisms and the Risk of Multiple System Atrophy

N. Abramycheva, M. Andreev, L. Karan, I. Minaev, A. Protopopova, A. Protsenko, E. Fedotova, S. Illaroshkin (Moscow, Russian Federation)
Analysis showed resemblance in Genetic architecture of rare movement disorders in consanguineous Pashtoon ethnic group

S. Rehman (Bannu, Pakistan)
Analyzing Longitudinal Correlation Between CSF Tau, Alpha-Synuclein, and Dysautonomia in Parkinson’s Disease Over Five Years

C. Song, J. Ruiz Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)
Anterior Pallidal Stimulation for Severe Tourette Syndrome: Open Phase Outcomes

P. Limousin, T. Foltynie, V. Lind, M. Krueger, H. Akram, J. Esperida, C. Milabo, H. Tyagi, D. Bindman, M. Silverdale, G. Auld, H. Sims, K. Chowdhury, N. Ahmed, A. King, L. Zrinzo, E. Joyce (London, United Kingdom)
Anti Yo-1 Antibody Syndrome: A Case Study of a Paraneoplastic Syndrome Mimicking Atypical Parkinsonism

R. Rodriguez (San Jose, Costa Rica)
Anti-diabetic Drug Use and the Risk of Parkinson’s Disease among Older Adults in Japan: the LIFE Study

Y. Kimura, S. Ge, T. Kitamura, L. Zha, Y. Shimomura, M. Komatsu, Y. Gon, S. Komukai, M. Maeda, K. Kiyohara, H. Mochizuki, H. Fukuda (Suita, Japan)
Anti-Diabetic Medications to Fight Parkinson’s Disease and Lewy Body Dementia

T. Chmiela, J. Dulski, Z. Parrales, Z. Wszolek, J. Wilson (Jacksonville, USA)
Anti-Parkinsonian effects of Globimetula cupulata leaf extract and its underlying mechanisms in 6-hydroxydopamine-lesioned rat model

A. Hamadjida, R. Ayissi Mbomo, S. Minko, F. Ntchapda, J. Mingoas Kilekoung (BERTOUA, Cameroon)
Anti-Yo Syndrome Presenting as an Isolated Head Tremor with Vertigo

P. Atit, V. Mazo, R. Hurst, A. Rivera Cruz (Tampa, USA)
Antidepressants Associated with Worsening Dyskinesia in Parkinson’s Disease

JV. Costa, EF. Muricy, FS. Brito, GS. Nunes, SC. Baran, GV. de Vasconcelos, CF. Do Nascimento, NS. Dos Santos, JX. Oliveira, ME. Vassoler, FG. Nascimento, AM. Guerra, RB. Kauark (Salvador, Brazil)
Antiparkinson Medication Reduces the Probability of the Multiple Step Saccade Pattern During a Memory-Guided Saccade Task

M. Munoz, J. Reilly, E. Zou, Y. Rivera, G. Pal, L. Verhagen Metman, L. Goelz, D. Corcos, F. David (Chicago, USA)
AntiSaccadeNet: A Deep Learning Framework for Differentiating Parkinsonian Disorders through Antisaccade Time Series Classification

S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)
Antisense Oligonucleotide Treatment in Ataxia-Telangiectasia

C. de Gusmao, C. Achkar, B. Ahtam, C. Berde, L. Bush, D. Chin, B. Darras, K. Faour, D. Friedmann, B. Gagoski, B. Goodlett, E. Grant, A. Gupta, S. Hills, A. Hu, J. Kim, A. Kuniholm, C. Lentucci, J. Lopes, E. Lopez, A. Luddy, B. Margus, M. Meserve, V. Natale, T. Nakayama, A. O’Connor, C. Rabideau, O. Riccardi, R. Schule, E. Sherril, L. Solo, A. Soucy, V. Suslovitch, M. Synofzik, J. Thornton, T. Yu (Boston, USA)
AOA1 Versus AOA2 : A Comparative Study Of A Tunisian Cohort

L. Hlioui, R. Zouari, R. Amouri, H. Kharrat, A. Rachdi, D. Ben Mohamed, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Apathy and Risk of Parkinson’s Disease: A Population-Based Cohort Study

A. Otaiku (London, United Kingdom)
Apolipoprotein E ɛ4-allele and Amygdala Atrophy in Parkinson’s Disease: A Preliminary Longitudinal Analysis from the ONDRI Cohort

U. Saeed, R. Bartha, M. Binns, S. Black, D. Grimes, R. Hegele, C. Marras, . Rogaeva, M. Lang, M. Masellis (Toronto, Canada)
Apomorphine Sublingual Film’s Efficacy in Elderly Patients with Parkinson’s Disease: Post-hoc Analysis of Study CTH-301

F. Moreira, L. Wojtecki, W. Jost, D. Santos Garcia, J. Kassubek, M. Fonseca, H. Brigas, G. Harrison-Jones, I. Pijuan (Duesseldorf, Germany)
Application of Multi-Camera Videography for Detecting PD-related Gait Deficiencies

R. Griesenauer, S. Dhulipalla, R. Trosch, W. Dauer (Boston, USA)
Application of Respiratory-Controlled Cardiopulmonary Coupling in Early Diagnosis of Parkinson’s Disease

HF. Zheng, PH. Zhu, J. Wang (najing, China)
Applying growth mixture models to elucidate heterogeneous trajectories of cognitive change in Parkinson’s Disease

M. Yang, C. Wang, D. Raymond, A. Wise, K. Leaver, V. Katsnelson, V. Shanker, M. Swan, C. Young, M. Beltre, M. Pullman, B. Green, N. Masood, A. Astefanous, A. Cohen, S. Bressman, R. Saunders-Pullman (New York, USA)
Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)
Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease

A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)
Apraxia of Speech as a Presenting Feature in AP3B2 Antibody Associated Cerebellar Ataxia

E. Ruether, A. Aksamit, D. Dubey, J. Stierwalt, S. Syc-Mazurek (Rochester, USA)
Aquatic Interval Training in Individuals with Parkinson’s Disease: Can It Improve Gait?

T. Christinelli, G. Leveck, L. Paladini, S. Souza, V. Israel (Curitiba, Brazil)
Archimedes spiral based non-linear regression machine learning model for predicting tremor’s severity

A. Rekik, S. Laatoui, M. Abid, R. Guizani, I. Rekik, S. Ben Amor (Sousse, Tunisia)
Are All Postural Reflexes Facilitated by Instability

J. Colebatch, D. Hochstrasser, N. Todd, S. Govender (Sydney, Australia)
Are Hallucinations in Parkinson’s Driven by Over-Reliance on Prior Information?

A. Holden, M. Macaskill, D. Myall, C. Le Heron, S. Lewis, T. Anderson, K-L. Horne (Christchurch, New Zealand)
Are There Differences in Non-Motor Outcomes of Parkinson’s Disease Treated with GPi vs. STN Deep Brain Stimulation?

G. Rodriguez Garcia, G. Hey, A. Martinez Nunez, J. Hilliard, A. Ramirez-Zamora (Gainesville, USA)
Are we there yet? A Comprehensive Assessment of the Challenges in Standardizing MRgFUS Outcomes in Essential Tremor

L. Knight, R. Martuscello, I. Pyle, A. Sanchez Fraga, C. Ferrer, K. Gant, A. Grinspan (Miami, USA)
Arginase2 – a potential mediator in the pathology of the stratum

M. Nalepa, K. Synoradzki, A. Skweres, A. Owczarek, M. Gewartowska, M. Wegrzynowicz (Warsaw, Poland)
Artificial Intelligence for Education in Movement Disorders

S. Garg, G. Amorelli (Ottawa, Canada)
Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics

L. Abu Zohair, H. Zantout, M. Vallejo, M. Uddin (Edinburgh, United Kingdom)
Artificial Intelligence in the Early Detection of Parkinson’s Disease: Advances, Challenges, and Future Perspectives

ME. Mellaci (SÃO PAULO, Brazil)
Artificial Intelligence Unveils Genetic Etiologies in Parkinson’s Disease: Cases Clustered by Clinical Features

G. Di Rauso, A. Ghibellini, F. Pirone, G. Franco, F. Arienti, E. Frattini, I. Trezzi, F. Cavallieri, L. Bononi, M. Gabbrielli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)
Assessing Disease Progression in MSA: Development of a Bayesian Progression Model

J. Wiedemann, C. Ebbesen, T. Jensen, M. Quintana, B. Wendelberger, W. Poewe, F. Krismer, S. Zanigni, J. Luthman (Valby, Denmark)
Assessing Genome-wide Genetic Risk for Parkinson’s Disease Age at Onset in European Sub-Populations: from the Global Parkinson’s Genetics Program

GP2. Parkinson'S_genetics_program (Bethesda, USA)
Assessing Individual Risk Through Determination of Local Ancestry: Insights from the Global Parkinson’s Genetics Program

M. Makarious, T. Leal, E. Waldo, D. Vitale, M. Koretsky, S. Hong, S. Yeboah, K. Levine, H. Leonard, M. Nalls, I. Mata, GP2. Parkinson'S_genetics_program (gp2) (Maryland, USA)
Assessing Physiotherapy’s Role in Parkinson’s Disease Functionality in India: A Case Report

K. Thangavelu (Gurugram, India)
Assessing the Impact of Interprofessional Education on Collaborative Practice in Neurorehabilitation for Parkinson’s Disease: A Systematic Review

Y. Hamdi, S. Elsenbawy, G. Abozeid, D. W. Ismail, H. Elshazly, M. Elsayed (Giza, Egypt)
Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients

HM. Chaparro-Solano, E. Waldo, T. Peixoto-Leal, AF. Schumacher-Schuh, BL. Santos-Lobato, E. Gatto, G. Arboleda, JL. Orozco-Velez, P. Chana-Cuevas, D. Aguillon, M. Rodriguez-Violante, D. Martinez-Ramirez, M. Cornejo-Olivas, A. Vinuela, G. Alvarado, P. Olguín, S. Alcauter, IF. Mata (Cleveland, USA)
Assessing the Relationship Between Autonomic Symptom Burden and Autonomic Failure in Parkinson’s Disease

F. Sadeghifar, N. Browner, E. Dayan, M. Sklerov (Chapel Hill, USA)
Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)
Assessment of Hypomimia in Parkinson’s Disease

T. Grover, T. Foltynie, J. Candelario, C. Milabo, C. Girges, M. Salazar, J. Esperida, P. Limousin (London, United Kingdom)
Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2

LE. Almaguer Mederos, D. Cuello Almarales, R. Aguilera Rodríguez, D. Almaguer Gotay, DO. Palenzuela Gardon, H. Camacho Rodríguez, A. Estupiñán Rodríguez, N. Canales Ochoa, S. Gispert, G. Auburger (Frankfurt am Main, Germany)
Assessment of Quality of Life in Patients with Hemifacial Spasm: Preliminary Report of a Case-Control Study

N. Durmaz Celik, N. Garipcin, E. Tatlı, M. Kuzu Kumcu, S. Ozkan (Eskisehir, Turkey)
Assessment of the Applicability of the King and PD-PCS Scales in Patients with Parkinson’s Disease and Chronic Pain: a Pilot Study

J. Queiroz, P. Matos, A. Ferreira Gomes, I. Santos, F. Rolim, D. de Andrade, F. Carvalho (Fortaleza, Brazil)
Assessment of the Impact of Environmental Factors on Disease Progression in Parkinson’s Disease

E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, W. Perkison, T. Krause (Austin, USA)
Assessment of the impact of the diabetic features hyperglycemia and insulin resistance on fibril induced synucleinopathy

S. Nelson, G. Barajas, A. Cole-Strauss, M. Kubik, C. Kemp, C. Sortwell, J. Patterson (Grand Rapids, USA)
Association Analysis Between Genotypes and Disease Progression in Parkinson’s Disease

ZY. Qi, YM. Sun, J. Wang (Shanghai, China)
Association between cognitive adverse effects of anticholinergic medication and development of long-term dementia in Parkinson’s disease

SH. Ha, BR. Jin, SY. Kim, SM. Lee, JH. Shin, HJ. Kim (Seoul, Republic of Korea)
Association between corneal sensitivity with vision-related quality of life and ocular surface symptoms in Parkinson’s disease

A. Camacho-Ordonez, M. Navarrete-Azuara, GR. Vera-Duarte, M. Rodriguez-Violante, A. Cervantes-Arriaga, AG. Alcocer-Salas, A. Ramirez-Miranda, EO. Graue-Hernandez (Mexico, Mexico)
Association Between Depression and Sleep Disorders in Parkinson’s Disease

J. Jiang, W. Wu, M. Mao (Suzhou, China)
Association between Freezing of Gait and Probable Sarcopenia in Patients with Parkinson’s Disease

AP. Loureiro, K. Santos, J. Souza (Curitiba, Brazil)
Association Between Heterozygous Loss-of-Function Variants in the MCOLN1 Gene and α-Synucleinopathies

CX. Ying, XH. Chen, ZD. Cen, W. Luo (Hangzhou, China)
Association Between Hyperuricemia, Gout, and the Risk of Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

F. Qtaishat, J. Yasin, R. Odat, M. Alsufi, A. Abunamoos (Irbid, Jordan)
Association between Imaging Glymphatic Dysfunction Markers and Clinical Symptoms in Progressive Supranuclear Palsy

J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, I. Roura, A. Campabadal, N. Bargalló, C. Painous, M. Fernández, O. Brengaret, C. Brenlla, A. Cámara, E. Muñoz, F. Valldeoriola, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)
Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)
Association Between Trait Impulsivity and Freezing of Gait in People with Parkinson’s Disease

H. Cavalcanti, D. Dos Santos, G. Valença, E. Pinto, J. Oliveira-Filho, L. de Almeida (Cachoeira, Brazil)
Association of high-density lipoprotein cholesterol and related inflammatory index with neurodegeneration in drug-naïve dementia with Lewy bodies

T. Umehara, M. Mimori, M. Ozawa, T. Shiraishi, T. Kitagawa, M. Ikeda, H. Matsuno, S. Omoto, R. Sengoku, H. Murakami, Y. Iguchi (Tokyo, Japan)
Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease

N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross (Jacksonville, USA)
Association of periodontal pathogen with subtypes of motor symptoms of Parkinson’s disease

H. Yamada, M. Nakamori, H. Nishi, H. Naito, Y. Yamazaki, H. Maruyama (Hiroshima, Japan)
Association of sequence alterations in the promoter region of the RAB7L1 gene with lysosomal hydrolase activity in blood and reduced risk of Parkinson disease

K. Basharova, A. Bezrukova, K. Senkevich, G. Baydakova, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson’s disease

H. Oizumi, T. Hasegawa, I. Kawahata, T. Totsune, Y. Sugimura, T. Baba, H. Tanaka, T. Takahashi, M. Yoshioka, T. Sekimori, K. Fukunaga, A. Takeda (Sendai, Japan)
Associations between Inflammation and Sleep Quality in Parkinson’s Disease: Exploring the Potential Influence of Sex.

J. Cristini, V. Daneault, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, L. Rodrigues, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)
Asymmetric periodic lower limb movements and malignant hypertension as an initial manifestation of atypical posterior reversible encephalopathy syndrome (PRES)

W. Yoon (Seoul, Republic of Korea)
Asymptomatic GBA1 Mutation Carriers Have Increased Cortical Cholinergic Activity

M. Matarazzo, J. Mckenzie, S. Dhaliwal, Q. Miao, N. Vafai, R. Alcalay, V. Bruno, A. Lehman, J. Quinn, D. Raymond, D. Safarpour, J. Sarna, R. Saunders-Pullman, S. Sirrs, CP. Zabetian, V. Sossi, AJ. Stoessl (Vancouver, Canada)
Ataxia as Diagnostic Dilemmas in HIV- related-Encephalitis with Positive Autoantibodies

F. Dridi, R. Zouari, A. Rachdi, Z. Saied, S. Ben Sassi (Tunis, Tunisia)
Ataxia in PBC: The Overlooked Role of Fat-Soluble Vitamin Deficiency

M. Rajani, P. Prakash (Providence, USA)
Ataxia, the initial symptom in a patient with Huntington’s Disease and Acquired (non-Wilsonian) Hepatocerebral Degeneration

V. Montero, N. Valdés, á. Pontoni, P. Salles (Santiago de Chile, Chile)
ATH434 Slowed Disease Progression in a Phase 2 Study in Multiple System Atrophy

D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, K. Kmiecik, D. Claassen (Newark, USA)
Atrophy In Multiple System Atrophy Relates To Mitochondrial And Oligodendrocytic Processes

L. Chougar, C. Tremblay, A. Delva, M. Filiatraul, A. Vo, J. Hansen, A. Farahani, B. Misic, P. Khalafi, CE. Castonguay, G. Rouleau, JC. Corvol, M. Vidailhet, B. Degos, D. Grabli, S. Lehéricy, A. Dagher, S. Rahayel (Montreal, Canada)
Attitudes Toward Research Among Asian Americans, Native Hawaiian, and Pacific Islanders and Whites with Parkinson’s disease in Hawaii.

E. Krening, R. Shuman, F. Gao, G. Ross, K. Thai, M. Faouzi, M. Bruno (Honolulu, USA)
Atypical Frontotemporal Dementia with Parkinsonism Linked to SQSTM1 Mutation A Clinicopathological Case Study

C. Espinoza Vinces, M. Zelaya Huerta, V. Coca Pueyo, G. Montoya Murillo, A. Patiño García, R. Villino Rodríguez, A. Atorrasagasti Villar, J. Arbizu, M. Riverol (Pamplona, Spain)
Atypical Onset and Presentation of Rare DYT30-VPS16 Dystonia

Y. Trufanov, E. Tsoma, M. Trishchynska, N. Khanenko, G. Chupryna, V. Sereda, A. Ovchynnykova (Prague, Czech Republic)
Atypical Parkinsonian Syndromes Presenting with Homonymous Hemianopsia

T. Le, D. Truong, M. Aung (Houston, USA)
Atypical Parkinsonism in the Setting of Normal Pressure Hydrocephalus and a Colloid Cyst: Diagnostic Challenge

QB. Nguyen, O. Los (Oklahoma City, USA)
Atypical Parkinsonism with LRRK2 Mutation Presenting as Multiple System Atrophy

K. Makhoul, R. Ramdhani (Great neck, USA)
Atypical presentation of Pantothenate Kinase-Associated Neurodegeneration in two siblings with a PANK-2 gene mutation: A case report and literature review.

H. Pacheco, V. Gómez, L. Núñez (Mexico, Mexico)
Atypical Psychosis in Parkinson Disease: A Retrospective Study on 24-Hour Continuous Subcutaneous Infusion Foslevodopa/Foscarbidopa Therapy

K. Ikenaka, K. Kakuda, Y. Kimura, H. Mochizuki (Suita, Japan)
Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)
Auditory Musical Hallucinations in Parkinson’s disease: A Case Series

T. Torabi, I. Bledsoe (San Francisco, USA)
Autoimmune GFAP astrocytopathy as an Etiology of Opsoclonus-Myoclonus-Ataxia Syndrome

T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)
Automated Image-Guided Programming Algorithm Supports Clinicians During DBS Programming for Parkinson’s Disease Patients

J. Aldred, C. Luca, A. Ramirez-Zamora, J. Wong, K. Wessels, T. Peabody, B. Reese, B. Farber Petrey, R. Mustakos, S. Niketeghad, R. Shivacharan, M. Malekmohammadi (Valencia, USA)
Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach

T. Thies, F. Dörr, A. König, N. Linz, M. Barbe, J. Orozco-Arroyave, J. Rusz, J. Tröger (Saarbrücken, Germany)
Automatic Quantification of Basal Ganglia Calcification Burden in Chinese Population

J. Li, H. Wang, B. Wang, Z. Cen, X. Chen, W. Luo (Hangzhou, China)
Automatic quantification of motor symptoms including freezing of gait in Parkinson’s disease through motion capture

W. Sako, M. Osawa, T. Iguchi, T. Hara, H. Haginiwa, S. Haji, N. Hattori (Bunkyo, Japan)
Automating the assessment of motor symptoms of Parkinson’s: exploring the scope of assessment possible in a video-based approach.

A. Podlewska, R. Singh, M. Squires, B. Bridges (London, United Kingdom)
Autonomic Nervous System Dysfunction in Patients with Huntington’s Disease: Preliminary Results Using the COMPASS-31 Scale

J. Patino, S. Zadegan, N. Rocha, E. Furr Stimming (Houston, USA)
Autosomal dominant ataxias expression profiles based on distinct clinical phenotypes.

F. Shen (Chicago, USA)
Autosomal Dominant DHDDS-Related Movement Disorder Treated with Primidone

D. Dewey, M. Khalaf, M. Hoerth, M. Osundiji, J. Caviness, S. Chiu (Scottsdale, USA)
Aversions as Triggers for Tic Exacerbations

M. Siegel, P. Graese, I. Malaty (Gainesville, USA)
Awareness and Implementation of Advanced Care Planning in Patients with Neurodegenerative Diseases

T. Osada, M. Ohira, K. Kimura, T. Sano, M. Takao (Kodaira, Tokyo, Japan)
Axis Characteristics of Oscillatory Head Movements in Cervical Dystonia

T. Hart, D. Martino, L. Heideman, M. Beudel, A. Sadnicka, F. Morgante (London, United Kingdom)